Will McCarthy

COO
Will has nearly thirty years of healthcare industry experience and leads multiple corporate functions including business development, finance, investor relations, human resources, new product planning and program management. Prior to joining Genesis, Will was Chief Business Officer at Generation Bio where he helped drive corporate strategy initiatives including the company’s Initial Public Offering. Previously he was Chief Business Officer at Ignyta, where he was responsible for commercial strategy and was a key participant in the company’s acquisition by Roche. Earlier in his career he held positions of increasing responsibility at Foundation Medicine, Halozyme and Neurocrine. Will has an MBA from London Business School and a BA from Exeter University.
Will McCarthy

Join Us

Our success stems from a uniquely potent mix of collaborative minds across AI and biotech.

In the News

We are proud to enable the broader ML research ecosystem through publications and open-source contributions, academic collaborations, and conference sponsorships.
December 2, 2025

Genesis Molecular AI Appoints Sergey Edunov as Senior Vice President of Foundation Models, Further Strengthening Leadership in Machine Learning

October 28, 2025

Introducing Pearl: The Next Generation Foundation Model for Drug Discovery